Lucchini Giovanna, Willasch Andre Manfred, Daniel Julia, Soerensen Jan, Jarisch Andrea, Bakhtiar Shahrzad, Rettinger Eva, Brandt Joerg, Klingebiel Thomas, Bader Peter
Division for Stem Cell Transplantation and Immunology, Department for Children and Adolescents, University Hospital, Goethe University, Frankfurt/Main, Germany.
Stem Cell Transplantation Unit, Pediatric Department, Great Ormond Street Hospital, London, United Kingdom.
Pediatr Transplant. 2016 Dec;20(8):1132-1136. doi: 10.1111/petr.12831. Epub 2016 Oct 13.
CLS involves sudden loss of intravascular fluids into the interstitial spaces. CLS was described as a possible complication after SCT. Few studies report the incidence of CLS in pediatric populations. We aimed to assess CLS incidence, its risk factors, and impact on the survival. The clinical charts of patients <18 years of age transplanted at our institution between 2002 and 2012 were reviewed. CLS was defined by weight gain >3% in 24 hours and positive intake balance despite furosemide administration. In total, 234 patients underwent 275 allogeneic SCT procedures in the analyzed time frame. Fifteen patients developed CLS (5.4%). The probability of developing CLS was significantly increased in patients suffering from sepsis (14.3% vs 0.6%, P<.001). Patients with CLS exhibited an increased risk of acute GvHD in the first 30 days after SCT (10.8% vs 1.8%, P=.002). Ten of the patients with CLS required intensive care. CLS strongly impacts OS at day +100 after SCT and is a predictive factor of TRM at the same date (42.9% vs 5%, P<.0001). The biological relation among sepsis, GvHD, and CLS development in terms of cytokine release and endothelial damage warrants further studies.
毛细血管渗漏综合征(CLS)涉及血管内液体突然渗漏到间质间隙。CLS被描述为造血干细胞移植(SCT)后的一种可能并发症。很少有研究报道儿科人群中CLS的发生率。我们旨在评估CLS的发生率、危险因素及其对生存的影响。我们回顾了2002年至2012年在我们机构接受移植的18岁以下患者的临床病历。CLS的定义为在24小时内体重增加>3%且尽管使用了呋塞米但摄入平衡仍为正值。在分析的时间范围内,共有234例患者接受了275次异基因SCT手术。15例患者发生了CLS(5.4%)。脓毒症患者发生CLS的概率显著增加(14.3%对0.6%,P<0.001)。发生CLS的患者在SCT后30天内发生急性移植物抗宿主病(GvHD)的风险增加(10.8%对1.8%,P = 0.002)。10例发生CLS的患者需要重症监护。CLS对SCT后第100天的总生存期有强烈影响,并且是同一日期移植相关死亡率(TRM)的预测因素(42.9%对5%,P<0.0001)。脓毒症、GvHD和CLS发生在细胞因子释放和内皮损伤方面的生物学关系值得进一步研究。